Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Keep Talking Justice Reform: MP
NRP Warn of Opioid Overdose Surge
Teenagers Wanted After Welland Car Crash
Nurse Practitioner Impacting Niagara Falls ER
Grimsby, Port Colborne Honour Remembrance Day
St. Catharines Man Charged with Drug Dealing
Wainfleet Man Wins Lottery... 1st Time
MP Plans to Hear More Vaccine Injury Stories